![](/images/graphics-bg.png)
Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban
Joint Authors
Hermans, Cedric
Boban, Ana
Lambert, Catherine
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-06-29
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet’s disease by a novel anticoagulant drug, rivaroxaban (Xarelto®).
To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting.
Our findings are promising; the outcome was favourable without any adverse effect noted.
We propose that the patients with Behçet’s disease and venous thrombosis might benefit from the advantages of the new anticoagulant drug.
American Psychological Association (APA)
Boban, Ana& Lambert, Catherine& Hermans, Cedric. 2016. Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban. Case Reports in Hematology،Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1100837
Modern Language Association (MLA)
Boban, Ana…[et al.]. Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban. Case Reports in Hematology No. 2016 (2016), pp.1-3.
https://search.emarefa.net/detail/BIM-1100837
American Medical Association (AMA)
Boban, Ana& Lambert, Catherine& Hermans, Cedric. Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban. Case Reports in Hematology. 2016. Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1100837
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1100837